Study: NCT06150014

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: TQA3605 placebo tablets were orally administered on an empty stomach (at least 2 hours before or after meals) with warm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: TQA3605 placebo tablets were orally administered on an empty stomach (at least 2 hours before or after meals) with warm.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQA3605 tablets
Description: TQA3605 inhibits viral replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQA3605 tablets
Description: TQA3605 inhibits viral replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQA3605 tablets
Description: TQA3605 inhibits viral replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQA3605 tablets
Description: TQA3605 inhibits viral replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQA3605 tablets
Description: TQA3605 inhibits viral replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQA3605 tablets
Description: TQA3605 inhibits viral replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Entecavir dispersible tablets
Description: Entecavir inhibits viral replication and indicated for chronic hepatitis B treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tenofovir disoproxil fumarate tablet
Description: Tenofovir disoproxil fumarate is a Nucleotide reverse transcriptase inhibitor.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir alafenamide fumarate tablet
Description: Tenofovir alafenamide fumarate inhibits hepatitis B virus replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir alafenamide fumarate tablet
Description: Tenofovir alafenamide fumarate inhibits hepatitis B virus replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir alafenamide fumarate tablet
Description: Tenofovir alafenamide fumarate inhibits hepatitis B virus replication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir alafenamide fumarate tablet
Description: Tenofovir alafenamide fumarate inhibits hepatitis B virus replication.